Amphastar Pharmaceuticals Current Ratio 2012-2024 | AMPH
Amphastar Pharmaceuticals current ratio from 2012 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Amphastar Pharmaceuticals Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-09-30 |
$0.55B |
$0.16B |
3.43 |
| 2024-06-30 |
$0.48B |
$0.14B |
3.52 |
| 2024-03-31 |
$0.56B |
$0.26B |
2.18 |
| 2023-12-31 |
$0.49B |
$0.23B |
2.17 |
| 2023-09-30 |
$0.54B |
$0.26B |
2.11 |
| 2023-06-30 |
$0.39B |
$0.25B |
1.53 |
| 2023-03-31 |
$0.41B |
$0.11B |
3.86 |
| 2022-12-31 |
$0.38B |
$0.10B |
3.99 |
| 2022-09-30 |
$0.38B |
$0.10B |
3.76 |
| 2022-06-30 |
$0.38B |
$0.10B |
3.64 |
| 2022-03-31 |
$0.36B |
$0.11B |
3.19 |
| 2021-12-31 |
$0.32B |
$0.10B |
3.06 |
| 2021-09-30 |
$0.30B |
$0.10B |
3.10 |
| 2021-06-30 |
$0.31B |
$0.13B |
2.50 |
| 2021-03-31 |
$0.30B |
$0.13B |
2.36 |
| 2020-12-31 |
$0.28B |
$0.11B |
2.49 |
| 2020-09-30 |
$0.28B |
$0.10B |
2.86 |
| 2020-06-30 |
$0.27B |
$0.09B |
2.86 |
| 2020-03-31 |
$0.25B |
$0.08B |
2.96 |
| 2019-12-31 |
$0.26B |
$0.09B |
2.84 |
| 2019-09-30 |
$0.27B |
$0.09B |
3.11 |
| 2019-06-30 |
$0.28B |
$0.10B |
2.81 |
| 2019-03-31 |
$0.23B |
$0.11B |
2.06 |
| 2018-12-31 |
$0.22B |
$0.11B |
2.06 |
| 2018-09-30 |
$0.20B |
$0.10B |
2.02 |
| 2018-06-30 |
$0.17B |
$0.09B |
1.94 |
| 2018-03-31 |
$0.17B |
$0.07B |
2.40 |
| 2017-12-31 |
$0.19B |
$0.07B |
2.80 |
| 2017-09-30 |
$0.18B |
$0.06B |
3.08 |
| 2017-06-30 |
$0.19B |
$0.06B |
3.04 |
| 2017-03-31 |
$0.19B |
$0.07B |
2.63 |
| 2016-12-31 |
$0.18B |
$0.06B |
3.04 |
| 2016-09-30 |
$0.19B |
$0.06B |
3.13 |
| 2016-06-30 |
$0.18B |
$0.07B |
2.76 |
| 2016-03-31 |
$0.17B |
$0.07B |
2.67 |
| 2015-12-31 |
$0.18B |
$0.06B |
2.93 |
| 2015-09-30 |
$0.20B |
$0.07B |
2.82 |
| 2015-06-30 |
$0.20B |
$0.07B |
2.94 |
| 2015-03-31 |
$0.20B |
$0.07B |
2.81 |
| 2014-12-31 |
$0.20B |
$0.06B |
3.16 |
| 2014-09-30 |
$0.22B |
$0.06B |
3.41 |
| 2014-06-30 |
$0.21B |
$0.06B |
3.81 |
| 2014-03-31 |
$0.18B |
$0.07B |
2.44 |
| 2013-12-31 |
$0.17B |
$0.07B |
2.65 |
| 2013-09-30 |
$0.00B |
|
0.00 |
| 2013-06-30 |
$0.00B |
|
0.00 |
| 2013-03-31 |
$0.00B |
|
0.00 |
| 2012-12-31 |
$0.17B |
$0.06B |
2.76 |
| 2012-09-30 |
$0.00B |
|
0.00 |
| 2012-06-30 |
$0.00B |
|
0.00 |
| 2012-03-31 |
$0.00B |
|
0.00 |
| 2011-12-31 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.894B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
